Nystatin Catalog No.:M9869-2 GSK-J4 could significant reduce LPS-induced

GSK-J4 could significant reduce LPS-induced pro-inflammatory cytokine production in primary human macrophages (IC50 ~9 μM for the inhibition of TNFα release)

CHR-2797 shows selectivity for transformed cells (MrC5-SV2 or K-ras NRK) over non-transformed cells (MrC5 or NRK)

Formula: C13H16N6O4

InChi: InChI=1S/C18H22F2N4O/c1-13-5-7-23(8-6-13)14(2)18(25

ARRY-470) is an ATP-competitive

Nystatin Catalog No.:M9869-2 GSK-J4 could significant reduce LPS-inducedNystatin is a polyene antifungal, the antibiotic complex containing three biologically active components: A1, A2, and A3. Nystatin is used to treat fungal infections of the skin, mouth, vagina, and intestinal tract. Fungal medicines will not work for colds, flu, or other viral infections. Nystatin binds to ergosterol, a major component of the fungal cell membrane. When present in sufficient concentrations, it forms pores in the membrane that lead to